Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › AAV vectors targeted to the central nervous system

AAV vectors targeted to the central nervous system

US Patent 11491242 · Granted Nov 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

UBE3A genes and expression cassettes and their use2025
Optimized GALC genes and expression cassettes and their use2025
Transgene cassettes designed to express a human MECP2 gene2025
Feedback enabled synthetic genes, target seed match cassettes, and their uses2025
Optimized CLN5 genes and expression cassettes and their use2025
Optimized FIG4 genes and expression cassettes and their use2025
Optimized CLN1 genes and expression cassettes and their use2025
Recombinant adeno-associated viral vector for gene delivery2025
AAV vectors targeted to oligodendrocytes2024
AAV vectors targeted to oligodendrocytes2024
Transgene cassettes, AAV vectors and AAV viral vectors for the expression of hum2024
Transgene cassettes designed to express a human MECP2 gene2024